Plasminogen activators in the human endometrium, cellular origin and hormonal regulation
Double bolus administration of the novel recombinant plasminogen activator BM 06.022 improves coronary blood flow after reperfusion in a canine model of coronary thrombosis
Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content
A non-occlusive model of arterial thrombus formation in the rat and its modification by inhibitors of platelet function, or thrombin activity
The inheritance of type I and type III von Willebrand's disease in Israel
The effect of exercise and heart rate on fibrinolytic activity
Determination of markers of coagulation activation and reactive fibrinolysis in patients with mechanical heart valve prosthesis at different intensities of oral anticoagulation
Heparin rebound phenomenon– much ado about nothing?
Fibrinolysis and fibrinogenolysis in patients with thrombotic disease
Comparison of fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator (t-PA) and fibrin-dependent enhancement of amidolytic activity of t-PA
Recommendations on choice of therapeutic products for the treatment of patients with haemophilia A, haemophilia B and von Willebrand's disease
Molecular link between membrane cholesterol and cyclic nucleotides in human platelets
Synergism between full length TFPI and heparin
Mechanisms in Blood Coagulation, Fibrinolysis and the Complement System
Info Select (Version 2.0) Personal Information Manager
WordPerfect 5.1 for Windows